Article
How clinically relevant are prostate cancer cell lines? A comprehensive characterisation and multiomics comparison
2024-03-21
Abstract excerpt
Cell line experiments arguably remain the most used tool in preclinical cancer research, despite their limitations. With almost 95% drugs entering human trials failing, and up to 90% preclinical research failing before even being tested in humans, we must shift the pre-clinical paradigm. A range of in silico, in vitro, in vivo and ex vivo approaches are gaining popularity, with the aim of potentially replacing cel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cacc50dc-3aeb-5b51-be00-dde15ed40534
- DOI
- 10.1101/2024.03.20.585982
